Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Vaccine Effectiveness × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 490 Neoplasms 470 Carcinoma, Non-Small-Cell Lung 398 Prostatic Neoplasms 291 Lung Neoplasms 255 Colorectal Neoplasms 236 Neoplasm Metastasis 217 Multiple Myeloma 195 Leukemia, Myeloid, Acute 177 Ovarian Neoplasms 174 Pancreatic Neoplasms 149 Melanoma 143 Recurrence 135 Squamous Cell Carcinoma of Head and Neck 133 Carcinoma, Hepatocellular 124 Carcinoma, Renal Cell 116 Stomach Neoplasms 113 Brain Neoplasms 113 Urinary Bladder Neoplasms 111 Glioblastoma 106 Lymphoma, Non-Hodgkin 102 Head and Neck Neoplasms 100 Endometrial Neoplasms 100 Leukemia, Lymphocytic, Chronic, B-Cell 99 Triple Negative Breast Neoplasms 97 Precursor Cell Lymphoblastic Leukemia-Lymphoma 96 Lymphoma, Large B-Cell, Diffuse 93 Hematologic Neoplasms 93 Lymphoma 92 Glioma 88

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07256912 2026-03-24

CervALONE

International Agency for Research on Cancer

Phase 4 Not yet recruiting

Vaccine Effectiveness

Data powered by HemOnc (CC BY 4.0) Colophon ⚡